Cetera Investment Advisers’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Buy |
2,192
+260
| +13% | +$62.7K | ﹤0.01% | 2924 |
|
|
2025
Q1 | $471K | Buy |
1,932
+215
| +13% | +$52.4K | ﹤0.01% | 2897 |
|
|
2024
Q4 | $564K | Buy |
1,717
+29
| +2% | +$9.53K | ﹤0.01% | 2585 |
|
|
2024
Q3 | $565K | Sell |
1,688
-327
| -16% | -$109K | ﹤0.01% | 2555 |
|
|
2024
Q2 | $550K | Sell |
2,015
-516
| -20% | -$141K | ﹤0.01% | 2514 |
|
|
2024
Q1 | $875K | Buy |
2,531
+1,030
| +69% | +$356K | ﹤0.01% | 2180 |
|
|
2023
Q4 | $485K | Sell |
1,501
-652
| -30% | -$211K | ﹤0.01% | 1508 |
|
|
2023
Q3 | $772K | Buy |
2,153
+594
| +38% | +$213K | 0.01% | 1180 |
|
|
2023
Q2 | $591K | Sell |
1,559
-104
| -6% | -$39.4K | 0.01% | 1354 |
|
|
2023
Q1 | $797K | Sell |
1,663
-20
| -1% | -$9.58K | 0.01% | 1149 |
|
|
2022
Q4 | $708K | Buy |
1,683
+245
| +17% | +$103K | 0.01% | 1174 |
|
|
2022
Q3 | $1K | Buy |
1,438
+667
| +87% | +$464 | ﹤0.01% | 1703 |
|
|
2022
Q2 | $382K | Sell |
771
-401
| -34% | -$199K | 0.01% | 1261 |
|
|
2022
Q1 | $660K | Sell |
1,172
-210
| -15% | -$118K | 0.01% | 997 |
|
|
2021
Q4 | $1.04M | Buy |
1,382
+328
| +31% | +$248K | 0.02% | 793 |
|
|
2021
Q3 | $786K | Sell |
1,054
-103
| -9% | -$76.8K | 0.01% | 877 |
|
|
2021
Q2 | $745K | Buy |
1,157
+285
| +33% | +$184K | 0.01% | 898 |
|
|
2021
Q1 | $498K | Buy |
872
+383
| +78% | +$219K | 0.01% | 981 |
|
|
2020
Q4 | $285K | Buy |
+489
| New | +$285K | 0.01% | 1262 |
|